Application

17376416 · IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

Filed 2021-07-15 · Granted · Patent 11332518 (2022-05-17) The official file ↗The patent and its PDF ↗ · Art unit 1645 · Examiner Nita M Minnifield Typical · CPC C07K 16/1282 · Allergan, Inc. · Foley Hoag, LLP (w/AVR)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

2.1 mo

to disposition 10.1 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.